PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/170951 Please be advised that this information was generated on 2021-09-26 and may be subject to change. COLLECTION REVIEW Measuring Sperm DNA Fragmentation and Clinical Outcomes of Medically Assisted Reproduction: A Systematic Review and Meta- Analysis Maartje Cissen1, Madelon van Wely2*, Irma Scholten2, Steven Mansell3, Jan Peter de Bruin1, Ben Willem Mol4, Didi Braat5, Sjoerd Repping2, Geert Hamer2 1 Department of Obstetrics & Gynaecology, Jeroen Bosch Hospital, `s-Hertogenbosch, The Netherlands, 2 Center for Reproductive Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, 3 Department of Molecular and Cell Biology, University of California, Berkeley, California, United States of America, 4 The Robinson Institute/School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, Australia, 5 Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, The Netherlands a11111 *
[email protected] Abstract Sperm DNA fragmentation has been associated with reduced fertilization rates, embryo OPEN ACCESS quality, pregnancy rates and increased miscarriage rates. Various methods exist to test Citation: Cissen M, Wely Mv, Scholten I, Mansell sperm DNA fragmentation such as the sperm chromatin structure assay (SCSA), the sperm S, Bruin JPd, Mol BW, et al. (2016) Measuring chromatin dispersion (SCD) test, the terminal deoxynucleotidyl transferase mediated deox- Sperm DNA Fragmentation and Clinical Outcomes yuridine triphosphate nick end labelling (TUNEL) assay and the single cell gel electrophore- of Medically Assisted Reproduction: A Systematic sis (Comet) assay.